Literature DB >> 7850005

Neuroendocrine regulation of growth hormone.

J Bertherat1, M T Bluet-Pajot, J Epelbaum.   

Abstract

This short review is focused on the neuroendocrine regulation of growth hormone (GH) pulsatile secretory pattern and GH gene expression. The neuronal network involved in the central control of GH includes extrahypothalamic neurons such as the noradrenergic and cholinergic systems, which regulate the two antagonistic neurohormonal systems: somatostatin (SRIH) and GH-releasing hormone (GHRH). Intrahypothalamic Proopiomelanocortin- and Galanin-containing interneurons also participate in the regulation of SRIH and GHRH neuronal activity, which also is dependent on sex steroids and GH and/or insulin-like growth factor I (IGF-I) feedback. cAMP (controlled mainly by GHRH and SRIH), thyroid and glucocorticoid hormones. IGF-I and activin are among the factors that regulate GH gene expression at the transcriptional level and may play a role in somatotroph differentiation and proliferation during ontogeny as well as physiological and pathological states such as acromegaly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7850005     DOI: 10.1530/eje.0.1320012

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  24 in total

1.  Growth hormone-releasing hormone triggers pacemaker activity and persistent Ca2+ oscillations in rat somatotrophs.

Authors:  R Kwiecien; V Tseeb; A Kurchikov; C Kordon; C Hammond
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

Review 2.  Interactions of metabolic hormones, adipose tissue and exercise.

Authors:  Robert G McMurray; Anthony C Hackney
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 3.  Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2.

Authors:  J D Veldhuis; W S Evans; C Y Bowers; S Anderson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.633

4.  Pituitary development and physiology.

Authors:  Clement C Cheung; Robert H Lustig
Journal:  Pituitary       Date:  2007       Impact factor: 4.107

Review 5.  Drug-induced disorders of glucose metabolism. Mechanisms and management.

Authors:  J C Chan; C S Cockram; J A Critchley
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

6.  Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice.

Authors:  Eugene N Bush; Robin Shapiro; Michael E Brune; Victoria E Knourek-Segel; Brian A Droz; Thomas Fey; Emily Lin; Peer B Jacobson
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 7.  Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.

Authors:  Monica Gola; Mauro Doga; Stefania Bonadonna; Gherardo Mazziotti; Pier Paolo Vescovi; Andrea Giustina
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

Review 8.  Anatomy of the hypophysiotropic somatostatinergic and growth hormone-releasing hormone system minireview.

Authors:  Mariann Fodor; Claude Kordon; Jacques Epelbaum
Journal:  Neurochem Res       Date:  2006-04-04       Impact factor: 3.996

9.  The GH/IGF-1 Axis and Heart Failure.

Authors:  Graziella Castellano; Flora Affuso; Pasquale Di Conza; Serafino Fazio
Journal:  Curr Cardiol Rev       Date:  2009-08

10.  Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function.

Authors:  Astrid C Hauge-Evans; Aileen J King; Danielle Carmignac; Carolyn C Richardson; Iain C A F Robinson; Malcolm J Low; Michael R Christie; Shanta J Persaud; Peter M Jones
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.